#ESMO26: Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins
MADRID — In a testament to clinicians’ interest in Merck and Moderna’s personalized cancer vaccine data at this year’s European Society for Medical Oncology conference, the presidential symposium, which can seat thousands of people, was full ...
Delegates during the cancer vaccine presentation at ESMO in Madrid (Reynald Castaneda for Endpoints News) October 25, 2026 11:46 AM EDT Pharma Merck and Moderna's cancer vaccine data were 'a triumph of science.' And now, the work begins Nicole DeFeudis Senior Reporter MADRID — In a testament to clinicians’ interest in Merck and Moderna’s personalized cancer vaccine data at this year’s European Society for Medical Oncology conference, the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that